Lebrikizumab
ATC D11AH10 · 11 markets · 17 records
US 2 records · 1 strengths
- 250 mg/2 mLinjectionEBGLYSS
GB 2 records · 1 strengths
- 250 mg/2 mLinjectionEbglyss 250mg/2ml solution for injection pre-filled pensEbglyss 250mg/2ml solution for injection pre-filled syringes
CA 2 records · 1 strengths
- 125 mg/1 mLliquidEBGLYSS
AU 2 records · 2 strengths
- 125 mg/mLinjectionEBGLYSS lebrikizumab 250 mg/2 mL solution for injection autoinjector (pre-filled pen)
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
ES 2 records · 1 strengths
- 250 mginjectionEBGLYSS PRECARGADA
FR 2 records · 1 strengths
- 250 mg/2 mLinjectionEBGLYSS 250 mg, solution injectable en seringue préremplieEBGLYSS 250 mg, solution injectable en stylo prérempli
SG 1 records · 1 strengths
- 250 mg/2 mLinjectionEBGLYSS SOLUTION FOR INJECTION IN PRE-FILLED PEN 250MG/2ML
MX 1 records · 1 strengths
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
TW 1 records · 1 strengths
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
HK 1 records · 1 strengths
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.
A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.